annual EBIT:
$708.45M+$121.08M(+20.61%)Summary
- As of today (May 21, 2025), JAZZ annual earnings before interest & taxes is $708.45 million, with the most recent change of +$121.08 million (+20.61%) on December 31, 2024.
- During the last 3 years, JAZZ annual EBIT has risen by +$542.52 million (+326.96%).
- JAZZ annual EBIT is now at all-time high.
Performance
JAZZ EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$56.10M-$240.58M(-130.41%)Summary
- As of today (May 21, 2025), JAZZ quarterly earnings before interest & taxes is -$56.10 million, with the most recent change of -$240.58 million (-130.41%) on March 1, 2025.
- Over the past year, JAZZ quarterly EBIT has dropped by -$120.62 million (-186.97%).
- JAZZ quarterly EBIT is now -121.62% below its all-time high of $259.51 million, reached on September 30, 2024.
Performance
JAZZ quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$587.83M-$120.62M(-17.03%)Summary
- As of today (May 21, 2025), JAZZ TTM earnings before interest & taxes is $587.83 million, with the most recent change of -$120.62 million (-17.03%) on March 1, 2025.
- Over the past year, JAZZ TTM EBIT has increased by +$65.20 million (+12.47%).
- JAZZ TTM EBIT is now -19.33% below its all-time high of $728.67 million, reached on March 31, 2021.
Performance
JAZZ TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
JAZZ EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.6% | -187.0% | +12.5% |
| 3 y3 years | +327.0% | -172.9% | +635.9% |
| 5 y5 years | +34.5% | +70.6% | +190.1% |
JAZZ EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +938.0% | -121.6% | +78.9% | -17.0% | +795.3% |
| 5 y | 5-year | at high | +938.0% | -121.6% | +78.9% | -19.3% | +795.3% |
| alltime | all time | at high | +603.9% | -121.6% | +78.9% | -19.3% | +407.3% |
JAZZ EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$56.10M(-130.4%) | $587.83M(-17.0%) |
| Dec 2024 | $708.45M(+20.6%) | $184.47M(-28.9%) | $708.45M(+8.0%) |
| Sep 2024 | - | $259.51M(+29.8%) | $655.82M(+15.6%) |
| Jun 2024 | - | $199.95M(+209.9%) | $567.33M(+8.6%) |
| Mar 2024 | - | $64.51M(-51.1%) | $522.63M(-11.0%) |
| Dec 2023 | $587.37M(-794.8%) | $131.85M(-22.9%) | $587.37M(+209.7%) |
| Sep 2023 | - | $171.01M(+10.2%) | $189.65M(+389.4%) |
| Jun 2023 | - | $155.25M(+20.1%) | $38.75M(-220.0%) |
| Mar 2023 | - | $129.25M(-148.6%) | -$32.30M(-61.8%) |
| Dec 2022 | -$84.54M(-151.0%) | -$265.87M(-1421.8%) | -$84.54M(-137.6%) |
| Sep 2022 | - | $20.11M(-76.1%) | $225.09M(-2.4%) |
| Jun 2022 | - | $84.20M(+9.3%) | $230.72M(+188.8%) |
| Mar 2022 | - | $77.01M(+75.9%) | $79.88M(-51.9%) |
| Dec 2021 | $165.93M(-55.7%) | $43.77M(+70.1%) | $165.93M(-43.7%) |
| Sep 2021 | - | $25.74M(-138.6%) | $294.54M(-36.6%) |
| Jun 2021 | - | -$66.64M(-140.9%) | $464.37M(-36.3%) |
| Mar 2021 | - | $163.06M(-5.4%) | $728.67M(+94.4%) |
| Dec 2020 | $374.80M(-28.8%) | $172.38M(-11.9%) | $374.80M(+43.4%) |
| Sep 2020 | - | $195.57M(-1.1%) | $261.44M(+32.1%) |
| Jun 2020 | - | $197.66M(-203.6%) | $197.94M(-2.3%) |
| Mar 2020 | - | -$190.81M(-423.3%) | $202.63M(-61.5%) |
| Dec 2019 | $526.56M(-13.4%) | $59.01M(-55.3%) | $526.56M(-19.3%) |
| Sep 2019 | - | $132.07M(-34.7%) | $652.34M(-7.9%) |
| Jun 2019 | - | $202.35M(+52.0%) | $708.29M(+8.1%) |
| Mar 2019 | - | $133.13M(-28.0%) | $655.02M(+7.7%) |
| Dec 2018 | $607.96M(+17.2%) | $184.79M(-1.7%) | $607.96M(+7.9%) |
| Sep 2018 | - | $188.02M(+26.1%) | $563.53M(+22.6%) |
| Jun 2018 | - | $149.08M(+73.2%) | $459.74M(-2.2%) |
| Mar 2018 | - | $86.08M(-38.7%) | $470.28M(-9.4%) |
| Dec 2017 | $518.87M(-12.7%) | $140.35M(+66.6%) | $518.87M(-5.5%) |
| Sep 2017 | - | $84.23M(-47.2%) | $548.97M(-8.4%) |
| Jun 2017 | - | $159.62M(+18.5%) | $599.60M(-1.5%) |
| Mar 2017 | - | $134.68M(-21.0%) | $608.72M(+2.4%) |
| Dec 2016 | $594.39M(+20.6%) | $170.44M(+26.4%) | $594.39M(+11.6%) |
| Sep 2016 | - | $134.87M(-20.1%) | $532.66M(+0.8%) |
| Jun 2016 | - | $168.74M(+40.2%) | $528.35M(+6.9%) |
| Mar 2016 | - | $120.34M(+10.7%) | $494.19M(+0.3%) |
| Dec 2015 | $492.85M(+141.3%) | $108.72M(-16.7%) | $492.85M(-4.5%) |
| Sep 2015 | - | $130.56M(-3.0%) | $516.05M(+14.7%) |
| Jun 2015 | - | $134.57M(+13.1%) | $450.02M(+15.4%) |
| Mar 2015 | - | $119.00M(-9.8%) | $389.81M(+90.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | $204.27M(-39.0%) | $131.92M(+104.5%) | $204.27M(+23.1%) |
| Sep 2014 | - | $64.52M(-13.2%) | $165.88M(-17.6%) |
| Jun 2014 | - | $74.36M(-211.8%) | $201.31M(+0.7%) |
| Mar 2014 | - | -$66.54M(-171.1%) | $199.87M(-40.3%) |
| Dec 2013 | $334.87M(+72.4%) | $93.53M(-6.4%) | $334.87M(+9.3%) |
| Sep 2013 | - | $99.95M(+37.0%) | $306.45M(+17.5%) |
| Jun 2013 | - | $72.93M(+6.5%) | $260.71M(+14.9%) |
| Mar 2013 | - | $68.46M(+5.1%) | $226.96M(+16.8%) |
| Dec 2012 | $194.22M(+53.4%) | $65.12M(+20.1%) | $194.24M(+16.6%) |
| Sep 2012 | - | $54.20M(+38.3%) | $166.64M(+14.9%) |
| Jun 2012 | - | $39.19M(+9.6%) | $145.05M(+3.8%) |
| Mar 2012 | - | $35.74M(-4.7%) | $139.72M(+10.4%) |
| Dec 2011 | $126.58M(+178.2%) | $37.51M(+15.0%) | $126.58M(+23.7%) |
| Sep 2011 | - | $32.61M(-3.7%) | $102.32M(+21.6%) |
| Jun 2011 | - | $33.86M(+49.8%) | $84.15M(+38.2%) |
| Mar 2011 | - | $22.60M(+70.6%) | $60.88M(+33.8%) |
| Dec 2010 | $45.50M(+185.6%) | $13.25M(-8.3%) | $45.50M(+4.2%) |
| Sep 2010 | - | $14.44M(+36.5%) | $43.66M(+32.6%) |
| Jun 2010 | - | $10.58M(+46.4%) | $32.93M(+8.4%) |
| Mar 2010 | - | $7.23M(-36.6%) | $30.38M(+90.7%) |
| Dec 2009 | $15.93M(-111.3%) | $11.41M(+207.6%) | $15.93M(-191.4%) |
| Sep 2009 | - | $3.71M(-53.8%) | -$17.44M(-64.3%) |
| Jun 2009 | - | $8.03M(-211.2%) | -$48.89M(-53.0%) |
| Mar 2009 | - | -$7.22M(-67.1%) | -$104.02M(-26.0%) |
| Dec 2008 | -$140.60M(+1.3%) | -$21.96M(-20.9%) | -$140.60M(-20.7%) |
| Sep 2008 | - | -$27.74M(-41.1%) | -$177.39M(+5.9%) |
| Jun 2008 | - | -$47.09M(+7.5%) | -$167.44M(+2.7%) |
| Mar 2008 | - | -$43.81M(-25.4%) | -$163.10M(+17.5%) |
| Dec 2007 | -$138.78M(+77.8%) | -$58.74M(+230.1%) | -$138.78M(-27.4%) |
| Sep 2007 | - | -$17.80M(-58.4%) | -$191.27M(+18.2%) |
| Jun 2007 | - | -$42.75M(+119.4%) | -$161.80M(+50.7%) |
| Mar 2007 | - | -$19.48M(-82.5%) | -$107.37M(+37.6%) |
| Dec 2006 | -$78.05M(+36.6%) | -$111.23M(-1052.9%) | -$78.05M(+94.9%) |
| Sep 2006 | - | $11.67M(0.0%) | -$40.04M(-13.6%) |
| Jun 2006 | - | $11.67M(+18.7%) | -$46.35M(-12.0%) |
| Mar 2006 | - | $9.84M(-113.4%) | -$52.67M(-7.8%) |
| Dec 2005 | -$57.14M(+130.4%) | -$73.23M(-1465.9%) | -$57.14M(-455.3%) |
| Sep 2005 | - | $5.36M(0.0%) | $16.08M(+50.0%) |
| Jun 2005 | - | $5.36M(0.0%) | $10.72M(+100.0%) |
| Mar 2005 | - | $5.36M | $5.36M |
| Dec 2004 | -$24.80M | - | - |
FAQ
- What is Jazz Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual EBIT year-on-year change?
- What is Jazz Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly EBIT year-on-year change?
- What is Jazz Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals TTM EBIT year-on-year change?
What is Jazz Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of JAZZ is $708.45M
What is the all time high annual EBIT for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual earnings before interest & taxes is $708.45M
What is Jazz Pharmaceuticals annual EBIT year-on-year change?
Over the past year, JAZZ annual earnings before interest & taxes has changed by +$121.08M (+20.61%)
What is Jazz Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of JAZZ is -$56.10M
What is the all time high quarterly EBIT for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly earnings before interest & taxes is $259.51M
What is Jazz Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, JAZZ quarterly earnings before interest & taxes has changed by -$120.62M (-186.97%)
What is Jazz Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of JAZZ is $587.83M
What is the all time high TTM EBIT for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high TTM earnings before interest & taxes is $728.67M
What is Jazz Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, JAZZ TTM earnings before interest & taxes has changed by +$65.20M (+12.47%)